Russell, M E (2000) Cardiac allograft vasculopathy--a changing perspective. Z Kardiol 89 Suppl 9:IX/6-10
|
Grimm, P C; McKenna, R; Nickerson, P et al. (1999) Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages. J Am Soc Nephrol 10:1582-9
|
Raisanen-Sokolowski, A; Glysing-Jensen, T; Russell, M E (1999) Donor and recipient contributions of ICAM-1 and P-selectin in parenchymal rejection and graft arteriosclerosis: insights from double knockout mice. J Heart Lung Transplant 18:735-43
|
Glysing-Jensen, T; Raisanen-Sokolowski, A; Sayegh, M H et al. (1997) Chronic blockade of CD28-B7-mediated T-cell costimulation by CTLA4Ig reduces intimal thickening in MHC class I and II incompatible mouse heart allografts. Transplantation 64:1641-5
|
Raisanen-Sokolowski, A; Glysing-Jensen, T; Mottram, P L et al. (1997) Sustained anti-CD4/CD8 treatment blocks inflammatory activation and intimal thickening in mouse heart allografts. Arterioscler Thromb Vasc Biol 17:2115-22
|
Russell, M E; Raisanen-Sokolowski, A; Mottram, P et al. (1997) Knockout models of chronic cardiac rejection and graft arteriosclerosis: intimal thickening develops independent of Th1 and Th2 cytokines. Transplant Proc 29:2531-2
|
Raisanen-Sokolowski, A; Mottram, P L; Glysing-Jensen, T et al. (1997) Heart transplants in interferon-gamma, interleukin 4, and interleukin 10 knockout mice. Recipient environment alters graft rejection. J Clin Invest 100:2449-56
|